Hereditary Cancers: BRCA-related cancers, Lynch syndrome-related cancers.

Hereditary cancers result from genetic mutations passed through families, increasing susceptibility to certain cancer types. BRCA1 and BRCA2 mutations are strongly associated with breast, ovarian, and pancreatic cancers, with targeted therapies like PARP inhibitors showing promise. Lynch syndrome-related cancers, including colorectal and endometrial cancers, are addressed through genetic counseling, regular screenings, and immunotherapy options. Research in hereditary cancers prioritizes identifying mutation carriers, understanding gene-environment interactions, and developing prevention strategies. The integration of genetic testing into clinical practice aids in early detection and personalized treatment planning.